Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOndo Insurtech Regulatory News (ONDO)

Share Price Information for Ondo Insurtech (ONDO)

Share Price is delayed by 15 minutes
Get Live Data
6.85    0.05 (0.74%)
Bid:
6.70
Ask:
7.00
Spread: 0.30 (4.478%)
Market Cap: £10.26m
ONDO Live PriceLast checked at - London Stock Exchange

Intraday Ondo Insurtech Share Chart

Director/PDMR Share Dealing

11 Mar 2025 16:56

RNS Number : 2525A
Ondo InsurTech PLC
11 March 2025
 

11 March 2025

Ondo Insurtech Plc

("Ondo" or the "Company")

 

Director/PDMR Share dealing

 

Ondo Insurtech (LSE: ONDO), a leading company in claims prevention technology for home insurers, announces that Charlene Hill, spouse of Chief Executive, Craig Foster, exercised warrants over 125,000 ordinary shares of 5 pence each in the capital of the Company ("Ordinary Shares") at an exercise price of 25 pence per warrant on 7 March 2025 ("New Ordinary Shares"). On the same day, Charlene Hill also sold 105,000 Ordinary shares (to cover taxes and exercise costs) at a price of 35.8 pence, having previously held 250,000 Ordinary Shares. Following the warrant exercise and share sale Charlene Hill is now interested in 270,000 Ordinary Shares, which represents approximately 0.21% of the issued share capital of the Company.

 

The New Ordinary Shares have been admitted to listing on the Equity Shares (Transition) category of the Official List of the Financial Conduct Authority and to trading on the London Stock Exchange's main market for listed securities under the Company's block listing.

 

Charlene Hill's interests in the Company were acquired through her participation in the fundraising undertaken by the Company in March 2022 in conjunction with its acquisition of the entire issued share capital of LeakBot Limited by way of a reverse takeover. At that time Charlene Hill was not a person closely associated ("PCA") with Craig Foster for UK MAR purposes. Following their marriage in August 2023, Charlene Hill has been a PCA with Craig Foster and accordingly, her interests should have been incorporated with and reflected when reporting the interests of Craig Foster, but this disclosure was not made in error.

 

Craig Foster's interests in the Company as at 1 August 2023 were as set out below:

 

 

Shareholding at August 2023

% of issued share capital

Number of warrants

Number of share options

Craig Foster

1,779,567

2.23%

889,783

2,320,000

Charlene Hill

250,000

0.32%

125,000

-

Total

2,029,567

2.55%

1,014,783

2,320,000

 

Following the share sale and exercise of warrants described above, as at 11 March 2025, Craig Foster's beneficial interests in the Company are now:

 

 

Shareholding(1)

% of issued share capital

Number of warrants

Number of share options

Craig Foster

2,448,844

1.90%

-

3,920,000

 

(1) 270,000 Ordinary Shares are held by Craig Foster's wife

 

 

 

Enquiries

 

Ondo InsurTech Plc

Craig Foster, CEO

Kevin Withington, CFO

+44 (0) 800 783 9866

Dowgate Capital Ltd

(Broker & Financial Advisor)

Russell Cook

Nick Chambers

Charlie Hall

+44 (0) 20 3903 7715

 

Cassiopeia Services Ltd

(PR & Investor Relations)

Stefania Barbaglio

 +44 (0) 7949 690338

 

 

The information set out below is provided in accordance with the requirements of Article 19 of the Market Abuse Regulations.

 

1.

Details of PDMR / person closely associated with them ("PCA").

a)

Name

Charlene Hill

2

Reason for notification

a)

Position/Status

PCA - spouse of Craig Foster, Chief Executive and PDMR

b)

Initial Notification / amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer

or auction monitor

a)

Name

Ondo InsurTech Plc

b)

LEI

2138005Y5QBJQMOOI719

 

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial

Ordinary shares of 5 pence each

instrument, type of instrument

 

Identification code

ISIN: GB00BNVVGD77

b)

Nature of transaction

Exercise of warrants for ordinary shares

c)

Price(s) and volume(s)

Exercise of warrants over 125,000 Ordinary Shares at an exercise price of 25 pence per warrant

 

d)

Aggregated information

n/a

e)

Date of transaction

7 March 2025

f)

Place of transaction

Outside of a trading venue

 

 

1.

Details of PDMR / person closely associated with them ("PCA").

a)

Name

Charlene Hill

2

Reason for notification

a)

Position/Status

PCA - spouse of Craig Foster, Chief Executive and PDMR

b)

Initial Notification / amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer

or auction monitor

a)

Name

Ondo InsurTech Plc

b)

LEI

2138005Y5QBJQMOOI719

 

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial

Ordinary shares of 5 pence each

instrument, type of instrument

 

Identification code

ISIN: GB00BNVVGD77

b)

Nature of transaction

Sale of Ordinary Shares

c)

Price(s) and volume(s)

 

Price

Volumes

35.8p

105,000

 

 

d)

Aggregated information

n/a

e)

Date of transaction

7 March 2025

f)

Place of transaction

London Stock Exchange, Main Market (XLON)

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHQFLFFEXLEBBX
Date   Source Headline
20th Dec 20247:00 amRNSDirector/PDMR Shareholding
5th Dec 20241:22 pmRNSExercise of Options
5th Dec 202412:21 pmRNSTotal Voting Rights
4th Dec 20247:00 amRNSShare Incentive Plan Purchase
3rd Dec 20247:00 amRNSInterim Results
3rd Dec 20247:00 amRNSAlm. Brand Group to introduce LeakBot
2nd Dec 20247:00 amRNSTotal Voting Rights
26th Nov 20247:00 amRNSNew US Contract with Selective Insurance
25th Nov 20247:00 amRNSVendor Loan Note restructuring
19th Nov 202411:43 amRNSNotice of Interim Results & Investor Presentation
18th Nov 20247:00 amRNSNew LeakBot Rollout in Indiana
12th Nov 20247:00 amRNSNationwide Mutual expand LeakBot into 16 US States
8th Nov 20242:09 pmRNSHolding(s) in Company
5th Nov 20245:09 pmRNSDirector/PDMR Shareholding
3rd Oct 202412:19 pmRNSShare Incentive Plan Purchase
23rd Sep 20245:45 pmRNSResult of AGM
23rd Sep 20247:00 amRNSAGM Trading Statement
5th Sep 20247:00 amRNSDirector share dealing
3rd Sep 20247:00 amRNSContract with NFU Mutual
30th Aug 20247:00 amRNSNotice of AGM
2nd Aug 20244:48 pmRNSHolding(s) in Company
2nd Aug 20247:00 amRNSBlock Listing Update
30th Jul 20247:15 amRNSFull Year Results available on NSM
30th Jul 20247:00 amRNSUS Contract Win
29th Jul 20247:00 amRNSResults for Year ended 31 March 2024
22nd Jul 202411:00 amRNSNotice of Results
19th Jul 20242:46 pmRNSHolding(s) in Company
24th Jun 20247:30 amRNSDirector/PDMR Shareholding
11th Jun 202412:09 pmRNSDirector/PDMR Shareholding
10th Jun 202410:47 amRNSTR-1 Gervaise Heddle
10th Jun 20247:00 amRNSFurther US development
6th Jun 20247:00 amRNSAgeas UK to trial LeakBot
3rd Jun 20242:00 pmRNSResult of General Meeting
30th May 20243:03 pmRNSResult of Open Offer
20th May 20248:30 amRNSOndo achieve ISO27001:2022 certification
14th May 202411:31 amRNSResult of Placing
13th May 20244:35 pmRNSProposed Placing and Open Offer
29th Apr 20247:00 amRNSNationwide and LeakBot Deployment Update
16th Apr 20247:00 amRNSTrading Update
28th Mar 20247:00 amRNSTotal Voting Rights
22nd Mar 20243:10 pmRNSExercise of Options
29th Feb 20247:00 amRNSTotal Voting Rights
26th Feb 20247:00 amRNSNew Agreement with South West Water
21st Feb 20247:00 amRNSContract announcement
6th Feb 202411:37 amRNSBlock Listing Update
29th Jan 20247:00 amRNSOndo Shortlisted for 2023 Breakthrough Award
3rd Jan 20247:00 amRNSDeal to Accelerate LeakBot Distribution in Denmark
29th Dec 20237:00 amRNSTotal Voting Rights and Shares in issue update
8th Dec 202312:09 pmRNSHolding(s) in Company
1st Dec 20238:46 amRNSReplacement-Proposed placing to raise up to £1.08m

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.